Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
McKesson
Merck
Dow
McKinsey

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Litigation Details for Teikoku Pharma USA, Inc. v. Endo Pharmaceuticals, Inc. (N.D. Cal. 2014)

See Plans and Pricing

« Back to Dashboard

Teikoku Pharma USA, Inc. v. Endo Pharmaceuticals, Inc. (N.D. Cal. 2014)

Docket   Start Trial Date Filed 2014-06-17
Court District Court, N.D. California Date Terminated
Cause 28:1346 Breach of Contract Assigned To Edward John Davila
Jury Demand Plaintiff Referred To Howard R. Lloyd
Parties ENDO PHARMACEUTICALS, INC.; TEIKOKU PHARMA USA, INC.; TEIKOKU SEIYAKU CO., LTD.
Patents 5,827,529
Attorneys Daniel B. Asimow; David S. Elkins; Joseph Anthony Meckes; Noriyuki Shimoda
Firms Squire Patton Boggs (US) LLP; Squire Patton Boggs US LLP; Squire Sanders (US) LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Teikoku Pharma USA, Inc. v. Endo Pharmaceuticals, Inc.
The small molecule drug covered by the patent cited in this case is   Start Trial .

Details for Teikoku Pharma USA, Inc. v. Endo Pharmaceuticals, Inc. (N.D. Cal. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-06-17 1 United States Patent No. 5,827,529 (the “‘529 Patent”) to TSC, as assignee. The ‘529 Patent …Following issuance of the ‘529 Patent, TPU undertook to have the ‘529 Patent …TSC’s patent rights against third parties who file certifications of non-infringement or patent …not infringe any claim of the ‘529 Patent and that the ‘529 Patent was invalid. … 15 incurred in pursuing patent infringement claims against third parties. Despite External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
AstraZeneca
Moodys
McKinsey
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.